Get started
Author

Peter Marbach

Observed names: MARBACH, P, Marbach, Peter, P Marbach, P. MARBACH, P. Marbach, PETER MARBACH
Observed institutions: Novartis (Switzerland), Inserm, University of Oslo, University of Basel, University of Toronto, Aarhus University, Aix-Marseille Université, Queen Elizabeth Hospital Birmingham, Royal Victoria Infirmary, Aarhus University Hospital, University Hospital of Basel, ETH Zurich, Novartis (Japan), Novartis (United States), Schlosspark-Klinik, Hôpital Bichat-Claude-Bernard, Hôpital de la Timone, Sandoz Group AG (Switzerland), Institute of Molecular Biology and Biophysics, Université de la Méditerranée Aix-Marseille II, Academisch Ziekenhuis Rotterdam, Daniel den Hoed Kliniek, Freie Universität Berlin, Erasmus University Rotterdam
ORCID: 0009-0005-4781-6845
Observed ORCID: 0009-0005-4781-6845
OpenAlex ID: A5012311701
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
1982 · Wilfried Bauer, Ulrich Briner, et al. · Life Sciences · 1,332
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
1991 · W.H. Bakker, R. Albert, et al. · Life Sciences · 328
Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux
2003 · HaiQing Dai, Peter Marbach, et al. · Journal of Pharmacology and Experimental Therapeutics · 273
Sandostatin LAR in Acromegalic Patients: Long Term Treatment
1997 · Anette Kvistborg Fløgstad, Johan Halse, et al. · The Journal of Clinical Endocrinology & Metabolism · 176
PDF
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
1991 · W.H. Bakker, E.P. Krenning, et al. · Life Sciences · 174
Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin
1986 · J. Pless, W. Bauer, et al. · Scandinavian Journal of Gastroenterology · 155
Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients
1996 · I. Lancranjan, C. Bruns, et al. · Metabolism · 146
Intestinal Absorption of Octreotide: N‐Trimethyl Chitosan Chloride (TMC) Ameliorates the Permeability and Absorption Properties of the Somatostatin Analogue In Vitro and In Vivo
2000 · M. Thanou, J.C. Verhoef, et al. · Journal of Pharmaceutical Sciences · 145
Long‐Acting Octreotide and Prolonged‐Release Lanreotide Formulations Have Different Pharmacokinetic Profiles
2005 · Beatrice Astruc, Peter Marbach, et al. · The Journal of Clinical Pharmacology · 122
Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administration
1986 · E. del Pozo, M. Neufeld, et al. · European Journal of Endocrinology · 113
Uptake kinetics of the somatostatin receptor ligand [ 86 Y]DOTA- d Phe 1 -Tyr 3 -octreotide ([ 86 Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90 Y-labelled analogue
1999 · Frank Rösch, Hans Herzog, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 101
Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients
1995 · Ioana Lancranjan, C. Bruns, et al. · Metabolism · 90
Sandostatin® LAR® (microencapsulated octreotide acetate) in acromegaly: Pharmacokinetic and pharmacodynamic relationships
1996 · Peter Grass, Peter Marbach, et al. · Metabolism · 71
Sandostatin LAR in acromegalic patients: a dose-range study.
1995 · A K Fløgstad, J Halse, et al. · The Journal of Clinical Endocrinology & Metabolism · 71
SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
1993 · Rainer Albert, Peter Marbach, et al. · Life Sciences · 70
Poly(alkyl cyanoacrylate) Nanocapsules as a Delivery System in the Rat for Octreotide, a Long-acting Somatostatin Analogue
1997 · Christiane Damgé, Jacky Vonderscher, et al. · Journal of Pharmacy and Pharmacology · 63
New evidence for growth hormone modulation by the α-adrenergic system in man
1977 · Ioana Lancranjan, P. Marbach · Metabolism · 53
Clinical Applications of Somatostatin Analogs
1985 · Peter Marbach, Michael Neufeld, et al. · Advances in experimental medicine and biology · 52
Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
1989 · M Lemaire, M Azria, et al. · Drug Metabolism and Disposition · 50
Endocrine Effect of a Methionine-Enkephalin Derivative (FK 33-824) in Man
2008 · Emilio del Pozo, Beat von Graffenried, et al. · Hormone Research · 41
Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients
2006 · Paul Salm, Christopher Warnholtz, et al. · Clinical Biochemistry · 39
Salmon calcitonin binding sites in rat pituitary
1983 · R. Maurer, P. Marbach, et al. · Brain Research · 39
Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactin.
1975 · E del Pozo, L Varga, et al. · PubMed · 38
Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin
2003 · Eleni V. Dimaraki, Craig A. Jaffe, et al. · American Journal of Physiology-Endocrinology and Metabolism · 37
From somatostatin to Sandostatin®: Pharmacodynamics and pharmacokinetics
1992 · P. Marbach, U. Briner, et al. · Metabolism · 35
Works count: 102
Citation count: 4,388
H-index: 30
I10-index: 48
Year
Topic
Type